References
- Winder C, Fonteyn P, Balouet J-C. Aerotoxic syndrome: a descriptive epidemiological survey of aircrew exposed to in-cabin airborne contaminants. J Occup Health Safety-Aust NZ. 2002;18:321–338.
- Schuchardt S, Koch W, Rosenberger W. Cabin air quality- quantitative comparison of volatile air contaminants at different flight phases during 177 commercial flights. Building Environm. 2019;148:498–507.
- Abou-Donia MB, Abou-Donia MM, ElMasry EM, et al. Autoantibodies to nervous system-specific proteins are elevated in sera of flight crew members: biomarkers for nervous system injury. J Toxicol Environ Health. 2013;76:363–380.
- Coxon LW. Delayed cognitive impairment and pilot incapacitation following contaminated air inhalation. JBPC 2014;14:107–110.
- Mackenzie Ross S. Cognitive function following exposure to contaminated air on commercial aircraft: a case series of 27 pilots seen for clinical purposes. J Nutrit Environ Med. 2008;17:111–126.
- Sánchez-Santed F, Colomina MT, Hernández EH. Organophosphate pesticide exposure and neurodegeneration. Cortex. 2016;74:417–426.
- Terry AV. Functional consequences of repeated organophosphate exposure: potential non-cholinergic mechanisms. Pharmacol Ther. 2012;134:355–365.
- Heutelbeck ARR, Bornemann C, Lange M, et al. Acetylcholinesterase and neuropathy target esterase activities in 11 cases of symptomatic flight crew members after fume events. J Toxicol Environ Health. 2016;79:1050–1056.
- Liyasova M, Li B, Schopfer LM, et al. Exposure to tri-o-cresyl phosphate detected in jet airplane passengers. Toxicol Appl Pharmacol. 2011;256:337–347.
- Costa LG, Vitalone A, Cole TB, et al. Modulation of paraoxonase (PON 1) activity. Biochem Pharmacol. 2005;69:541–550.
- Polimanti R, Piacentini S, Manfellotto D, et al. Human genetic variation of CYP450 superfamily: analysis of functional diversity in worldwide populations. Pharmacogenomics. 2012;13:1951–1960.
- Levin EC, Acharya NK, Han M, et al. Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood-brain barrier breakdown. Brain Res. 2010;1345:221–232.